Autolus Therapeutics
company in London, United Kingdom
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 7 annual filings
Revenue
$75.39M
Net Income
-$287.53M
Assets
$589.07M
EPS (diluted)
$-1.08
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001730463-26-000038Autolus Therapeutics
Summary
Autolus Therapeutics is a business[1]. It is known by 3 alternative names across languages and contexts.[2]
Key Facts
- Autolus Therapeutics is in the country of United Kingdom[3].
- Autolus Therapeutics is in the country of GB[4].
- Autolus Therapeutics's instance of is recorded as business[5].
- Autolus Therapeutics's instance of is recorded as public company[6].
- Autolus Therapeutics is owned by Syncona[7].
- Autolus Therapeutics is owned by PPF Capital Partners Fund[8].
- Autolus Therapeutics's stock exchange is recorded as Nasdaq[9].
- January 1, 2014 marks the founding of Autolus Therapeutics[10].
- 2018-02-02 marks the founding of Autolus Therapeutics[11].
- Autolus Therapeutics's coordinate location is recorded as {'lat': 51.514581, 'lon': -0.224554}[12].
- Autolus Therapeutics's official website is recorded as http://www.autolus.com/[13].
- Autolus Therapeutics's legal form is recorded as public limited company[14].
- Autolus Therapeutics's legal form is recorded as B6ES[15].
- Autolus Therapeutics's street address is recorded as THE MEDIAWORKS, 191 WOOD LANE, LONDON, ENGLAND, W12 7FP[16].
Body
Founding
Recorded inception include January 1, 2014[10] and 2018-02-02[11].
Ownership
Owners include Syncona[7], a business[17], in Guernsey[18], founded in 2012[19], headquartered in Saint Peter Port[20] and PPF Capital Partners Fund[8], a business[21], in Netherlands[22], founded in 2012[23], headquartered in Amsterdam[24]. Autolus Therapeutics's stock exchange is recorded as Nasdaq[9].
Why It Matters
Autolus Therapeutics is known by 3 alternative names across languages and contexts.[2]